文献速递创面修复显微修复重建

整形外科参与感染心室辅助装置的手术管理可降低终生重返手术室次数与90天感染并发症

Plastic Surgery Involvement With Surgical Management of Infected Ventricular Assist Devices Decreased Lifetime Return to Operating Room and 90-Day Infectious Complications.
PubMed 文献 · Ann Plast Surg · 2024-01-01

该单中心回顾性研究纳入2008至2021年因左心室辅助装置(LVAD)感染再入院的568例患者,其中104例行手术清创并分别由整形重建外科(PRS,53例)或心胸外科(CTS,51例)关闭。PRS组终生重返手术室(RTOR)风险低于CTS组(P=0.03),90天感染风险亦低于CTS组(P=0.007);

要点

  • LVAD感染清创后由PRS关闭者终生RTOR风险低于CTS关闭者(P=0.03)。
  • PRS关闭者90天感染风险低于CTS关闭者(P=0.007)。

核心结论

  • 整形外科参与感染LVAD装置的手术决策与关闭可降低终生RTOR及90天感染相关并发症,早期PRS会诊评估覆盖可能有益。

研究设计与样本

  • 单中心回顾性研究,利用既有数据库识别2008至2021年因LVAD感染再入院的患者,平均随访3.2年。
  • 568例因LVAD感染入院患者中104例行手术清创并由PRS(53例)或CTS(51例)关闭。
  • 采用χ2检验与方差分析比较结局。

主要发现

  • PRS组糖尿病发生率高于CTS组(P < 0.001),其余基线特征无差异。
  • CTS关闭者终生RTOR高于PRS关闭者(P = 0.03)。
  • CTS关闭者90天感染风险高于PRS关闭者(P = 0.007)。
  • PRS与CTS关闭者平均均在术后第7天出院(P = 0.542),PRS通常在住院第10天被会诊。

临床怎么用

  • 作者认为整形外科参与感染LVAD装置的手术决策与关闭可降低终生RTOR及90天感染相关并发症。
  • 作者认为早期PRS会诊评估覆盖可能有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of left ventricular assist devices (LVADs) for patients with end-stage cardiac failure awaiting heart transplantation has become increasingly common. However, ventricular assist device-related infections remain a major problem complicating their long-term use. Retrospective review has previously shown a decrease in lifetime return to operating room (RTOR) with no change in 90-day complications when a muscle or omental flap is used for coverage after washout for infection. We wished to determine if early plastic surgery intervention led to a decreased length of stay for these patients. METHODS: Patients with LVAD readmitted for LVAD infection at a single institution from 2008 to 2021 were identified using a preexisting database. Patients were followed retrospectively for an average of 3.2 years. Patient demographics, preoperative diagnosis/disease state, type of ventricular assist device inserted, postoperative day of ventricular assist device infection onset, definitive device coverage, timing of coverage procedure after the initial washout for infection, type of flap used for coverage, 90-day complications after definitive coverage, and lifetime return to operating room for infection were reviewed. Comparison analysis with χ2 and analysis of variance testing was used to analyze outcomes. RESULTS: Of 568 patients admitted with an LVAD infection, 104 underwent operative debridement and closure by plastic and reconstructive surgery (PRS) or cardiothoracic surgery (CTS). Fifty-three underwent PRS closure, and 51 underwent CTS closure. There was an increased incidence of diabetes among the PRS group (P < 0.001); otherwise, there was no difference in baseline characteristics. There was increased RTOR over a lifetime with CTS closure compared with PRS (P = 0.03) and increased 90-day risk of infection (P = 0.007). Patients with PRS closure had an increased risk of postoperative hematoma (P = 046). Plastic and reconstructive surgery was typically consulted on hospital day 10. Both PRS and CTS closure patients were discharged on postoperative day 7, on average (P = 0.542). CONCLUSIONS: Plastic surgery involvement with surgical decision making and closure of infected LVAD devices has a decrease in lifetime RTOR and decreased 90-day complications related to infections. There may be a benefit to earlier PRS consultation for coverage assessment.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Sweitzer K, Fowler C, Butterfield J, et al. Plastic Surgery Involvement With Surgical Management of Infected Ventricular Assist Devices Decreased Lifetime Return to Operating Room and 90-Day Infectious Complications. Ann Plast Surg. 2024. PMID: 38556673. doi:10.1097/SAP.0000000000003874

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。